BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 33662164)

  • 1. Validation of the Alternative International Prognostic Score-E (AIPS-E): Analysis of Binet stage A chronic lymphocytic leukemia patients enrolled into the O-CLL1-GISL protocol.
    Morabito F; Tripepi G; Vigna E; Bossio S; D'Arrigo G; Martino EA; Storino F; Recchia AG; Fronza G; Di Raimondo F; Colombo M; Fais F; Neri A; Cutrona G; Ferrarini M; Gentile M
    Eur J Haematol; 2021 Jun; 106(6):831-835. PubMed ID: 33662164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte Doubling Time As A Key Prognostic Factor To Predict Time To First Treatment In Early-Stage Chronic Lymphocytic Leukemia.
    Morabito F; Tripepi G; Moia R; Recchia AG; Boggione P; Mauro FR; Bossio S; D'Arrigo G; Martino EA; Vigna E; Storino F; Fronza G; Di Raimondo F; Rossi D; Condoluci A; Colombo M; Fais F; Fabris S; Foa R; Cutrona G; Gentile M; Montserrat E; Gaidano G; Ferrarini M; Neri A
    Front Oncol; 2021; 11():684621. PubMed ID: 34408978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The chronic lymphocytic leukemia international prognostic index predicts time to first treatment in early CLL: Independent validation in a prospective cohort of early stage patients.
    Molica S; Shanafelt TD; Giannarelli D; Gentile M; Mirabelli R; Cutrona G; Levato L; Di Renzo N; Di Raimondo F; Musolino C; Angrilli F; Famà A; Recchia AG; Chaffee KG; Neri A; Kay NE; Ferrarini M; Morabito F
    Am J Hematol; 2016 Nov; 91(11):1090-1095. PubMed ID: 27465919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of four prognostic scoring system in patients with early asymptomatic chronic lymphocytic leukemia patients].
    Sha YQ; Shen H; Wu W; Xia Y; Miao Y; Cao L; Wang L; Fan L; Xu W; Li JY; Zhu HY
    Zhonghua Xue Ye Xue Za Zhi; 2021 Oct; 42(10):834-839. PubMed ID: 34788923
    [No Abstract]   [Full Text] [Related]  

  • 5. Prognostic model for newly diagnosed CLL patients in Binet stage A: results of the multicenter, prospective CLL1 trial of the German CLL study group.
    Hoechstetter MA; Busch R; Eichhorst B; Bühler A; Winkler D; Bahlo J; Robrecht S; Eckart MJ; Vehling-Kaiser U; Jacobs G; Jäger U; Hurtz HJ; Hopfinger G; Hartmann F; Fuss H; Abenhardt W; Blau I; Freier W; Müller L; Goebeler M; Wendtner C; Fischer K; Herling CD; Starck M; Bentz M; Emmerich B; Döhner H; Stilgenbauer S; Hallek M
    Leukemia; 2020 Apr; 34(4):1038-1051. PubMed ID: 32042081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. External validation of International Prognostic Score for asymptomatic early stage chronic lymphocytic leukaemia and proposal of an alternative score.
    Smolej L; Turcsányi P; Kubová Z; Zuchnická J; Mihályová J; Šimkovič M; Vodárek P; Krčméryová M; Móciková H; Brejcha M; Špaček M;
    Br J Haematol; 2021 Apr; 193(1):133-137. PubMed ID: 33280081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic Lymphocytic Leukemia Prognostic Index: A New Integrated Scoring System to Predict the Time to First Treatment in Chinese Patients with Chronic Lymphocytic Leukemia.
    Li H; Yi SH; Xiong WJ; Liu HM; Lyu R; Wang TY; Liu W; Zhong SZ; Yu Z; Zou DH; Xu Y; An G; Li ZJ; Qiu LG
    Chin Med J (Engl); 2017 Jan; 130(2):135-142. PubMed ID: 28091403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective validation of a risk score based on biological markers for predicting progression free survival in Binet stage A chronic lymphocytic leukemia patients: results of the multicenter O-CLL1-GISL study.
    Gentile M; Cutrona G; Mosca L; Matis S; Fabris S; Lionetti M; Ilariucci F; Zupo S; Musolino C; Levato L; Molica S; Di Raimondo F; Vincelli I; Di Rienzo N; Pesce EA; Angrilli F; Federico M; Neri A; Ferrarini M; Morabito F
    Am J Hematol; 2014 Jul; 89(7):743-50. PubMed ID: 24711230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting Stage Progression in Binet Stage a Chronic Lymphocytic Leukemia.
    Alshemmari SH; Almazyad M; Alsarraf A; Kunhikrishnan A; Isaac AM; Kaempf A
    Hematol Oncol Stem Cell Ther; 2024 Mar; 17(2):137-145. PubMed ID: 38560969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia.
    Condoluci A; Terzi di Bergamo L; Langerbeins P; Hoechstetter MA; Herling CD; De Paoli L; Delgado J; Rabe KG; Gentile M; Doubek M; Mauro FR; Chiodin G; Mattsson M; Bahlo J; Cutrona G; Kotaskova J; Deambrogi C; Smedby KE; Spina V; Bruscaggin A; Wu W; Moia R; Bianchi E; Gerber B; Zucca E; Gillessen S; Ghielmini M; Cavalli F; Stussi G; Hess MA; Baumann TS; Neri A; Ferrarini M; Rosenquist R; Forconi F; Foà R; Pospisilova S; Morabito F; Stilgenbauer S; Döhner H; Parikh SA; Wierda WG; Montserrat E; Gaidano G; Hallek M; Rossi D
    Blood; 2020 May; 135(21):1859-1869. PubMed ID: 32267500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unavailability of thymidine kinase does not preclude the use of German comprehensive prognostic index: results of an external validation analysis in early chronic lymphocytic leukemia and comparison with MD Anderson Cancer Center model.
    Molica S; Giannarelli D; Mirabelli R; Levato L; Russo A; Linardi M; Gentile M; Morabito F
    Eur J Haematol; 2016 Jan; 96(1):72-7. PubMed ID: 25819739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective validation of predictive value of abdominal computed tomography scan on time to first treatment in Rai 0 chronic lymphocytic leukemia patients: results of the multicenter O-CLL1-GISL study.
    Gentile M; Cutrona G; Molica S; Ilariucci F; Mauro FR; Di Renzo N; Di Raimondo F; Vincelli I; Todoerti K; Matis S; Musolino C; Fabris S; Lionetti M; Levato L; Zupo S; Angrilli F; Consoli U; Festini G; Longo G; Cortelezzi A; Musto P; Federico M; Neri A; Ferrarini M; Morabito F
    Eur J Haematol; 2016 Jan; 96(1):36-45. PubMed ID: 25753656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total body computed tomography scan in the initial work-up of Binet stage A chronic lymphocytic leukemia patients: Results of the prospective, multicenter O-CLL1-GISL study.
    Gentile M; Cutrona G; Fabris S; Pesce EA; Baldini L; Di Raimondo F; Musolino C; Di Tonno P; Di Renzo N; Molica S; Brugiatelli M; Ilariucci F; Zupo S; Matis S; Maura F; Vigna E; Angrilli F; Recchia AG; Quarta G; Iannitto E; Fragasso A; Musto P; Spriano M; Vincelli I; Vallisa D; Cortelezzi A; Mauro FR; Foà R; Federico M; Neri A; Ferrarini M; Morabito F
    Am J Hematol; 2013 Jul; 88(7):539-44. PubMed ID: 23553682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of gene mutations with time-to-first treatment in 384 treatment-naive chronic lymphocytic leukaemia patients.
    Hu B; Patel KP; Chen HC; Wang X; Luthra R; Routbort MJ; Kanagal-Shamanna R; Medeiros LJ; Yin CC; Zuo Z; Ok CY; Loghavi S; Tang G; Tambaro FP; Thompson P; Burger J; Jain N; Ferrajoli A; Bose P; Estrov Z; Keating M; Wierda WG
    Br J Haematol; 2019 Nov; 187(3):307-318. PubMed ID: 31243771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGHV gene mutational status and 17p deletion are independent molecular predictors in a comprehensive clinical-biological prognostic model for overall survival prediction in chronic lymphocytic leukemia.
    Bulian P; Rossi D; Forconi F; Del Poeta G; Bertoni F; Zucca E; Montillo M; Pozzato G; D'Arena G; Efremov DG; Marasca R; Lauria F; Gaidano G; Gattei V; Laurenti L
    J Transl Med; 2012 Jan; 10():18. PubMed ID: 22289136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying patients with chronic lymphocytic leukemia without need of treatment: End of endless watch and wait?
    Brieghel C; Galle V; Agius R; da Cunha-Bang C; Andersen MA; Vlummens P; Mattsson M; Rosenquist R; Smedby KE; Herling CD; Bahlo J; Hallek M; Lundgren JD; Offner F; Niemann CU
    Eur J Haematol; 2022 May; 108(5):369-378. PubMed ID: 35030282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of prevalent chronic lymphocytic leukemia stereotyped subsets: analysis within prospective clinical trials of the German CLL Study Group (GCLLSG).
    Jaramillo S; Agathangelidis A; Schneider C; Bahlo J; Robrecht S; Tausch E; Bloehdorn J; Hoechstetter M; Fischer K; Eichhorst B; Goede V; Hallek M; Döhner H; Rosenquist R; Ghia P; Stamatopoulos K; Stilgenbauer S
    Haematologica; 2020 Nov; 105(11):2598-2607. PubMed ID: 33131249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prognostic algorithm including a modified version of MD Anderson Cancer Center (MDACC) score predicts time to first treatment of patients with clinical monoclonal lymphocytosis (cMBL)/Rai stage 0 chronic lymphocytic leukemia (CLL).
    Molica S; Giannarelli D; Levato L; Mirabelli R; Gentile M; Lentini M; Morabito F
    Int J Hematol; 2014 Sep; 100(3):290-5. PubMed ID: 25064370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers (IGHV mutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL-IPI.
    Delgado J; Doubek M; Baumann T; Kotaskova J; Molica S; Mozas P; Rivas-Delgado A; Morabito F; Pospisilova S; Montserrat E
    Am J Hematol; 2017 Apr; 92(4):375-380. PubMed ID: 28120419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemia.
    Pflug N; Bahlo J; Shanafelt TD; Eichhorst BF; Bergmann MA; Elter T; Bauer K; Malchau G; Rabe KG; Stilgenbauer S; Döhner H; Jäger U; Eckart MJ; Hopfinger G; Busch R; Fink AM; Wendtner CM; Fischer K; Kay NE; Hallek M
    Blood; 2014 Jul; 124(1):49-62. PubMed ID: 24797299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.